Inactive Instrument

Jilin Zixin Pharmaceutical Industrial Co.,Ltd. Share Price

Equities

002118

CNE000001R43

Pharmaceuticals

Dynamic Chart
Jilin Zixin Pharmaceutical Industrial Co.,Ltd.(SZSE:002118) dropped from Shenzhen Stock Exchange A Share Index CI
Jilin Zixin Pharmaceutical Industrial Co.,Ltd.(SZSE:002118) dropped from Shenzhen Stock Exchange Composite Index CI
Jilin Zixin Pharmaceutical Industrial Co.,Ltd. Approves Board Appointments CI
Jilin Zixin Pharma CFO Resigns; Successor Named; Shares Slump 5% MT
Jilin Zixin Pharmaceutical Industrial Co.,Ltd. Auditor Raises 'Going Concern' Doubt CI
Jilin Zixin Pharmaceutical Industrial Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Jilin Zixin Pharmaceutical Industrial Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Jilin Zixin Pharma Chairman Resigns MT
Jilin Zixin Pharmaceutical Industrial Co.,Ltd. Appoints Chen Fu as Non-Independent Directors CI
Jilin Zixin Pharma Elects Chairman MT
Jilin Zixin Pharmaceutical Industrial Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Jilin Zixin Pharmaceutical Industrial Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Jilin Zixin Pharmaceutical Industrial Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Jilin Zixin Pharmaceutical Industrial Co.,Ltd. Auditor Raises 'Going Concern' Doubt CI
Jilin Zixin Pharmaceutical Industrial Co.,Ltd. Announces Board Changes CI
More news
Managers TitleAgeSince
Chief Executive Officer - -
Director/Board Member 52 -
Director/Board Member 49 01/00/01
Members of the board TitleAgeSince
Director/Board Member 49 01/00/01
Director/Board Member 53 01/13/01
Director/Board Member 54 01/01/01
More insiders
JILIN ZIXIN PHARMACEUTICAL INDUSTRIAL CO., LTD is a China-based company, principally engaged in the research and development, production and distribution of traditional Chinese patent drugs and ginseng products. The Company operates its businesses through three segments. The Traditional Chinese Patent Drugs segment mainly provides traditional Chinese patent drugs for the treatment of rheumatoid immunity, ear-nose-throat (ENT), urinary system cardiovascular, hepatobiliary and digestive diseases. The Ginseng Products segment is engaged in the provision of deep processing products and rough-wrought products, including white ginseng products, red ginseng products, drinks and candied fruits. The Gene Sequencing segment is engaged in the research and development, manufacture and distribution of gene sequencing machines and supporting reagents.
More about the company
  1. Stock Market
  2. Equities
  3. 002118 Stock